Introduction Chronic thromboembolic pulmonary hypertension (CTEPH) is diagnosed in 0.1–3.8% of pulmonary embolism survivors [1] and its incidence in the general population is 5.2–13.2 million per year [2]. CTEPH is characterised by a dismal prognosis, secondary to right-sided heart-failure. Although several therapies exist, pulmonary endarterectomy (PEA) is preferred in suitable patients because it is potentially curative [3, 4].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Arthur
Contact Arthur, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack